CH3100 - Molecular Basis of Therapeutics 4
|Student Contribution Band:
Available to students who are enrolled in the BPharm, BPharm IHCAP Program and the
BPharm Honours Programs.
This subject will examine the medicinal chemistry relevant to the process of drug
discovery and development as practised in the modern pharmaceutical industry. Building
on the material covered in Pc2001 and Pc2002, it will develop in students a knowledge
of the research tools which are applied to this process including high throughput
screening, computational chemistry and molecular modelling, QSAR, combinatorial synthesis
techniques and the application of genomics. The specific application of these tools
to drug classes of clinical significance will be illustrated by a case-study approach.Assessment
by a three-hour examination (70%); drug profile assignment, participation in workshops
- an appreciation of the interdisciplinary nature of the drug discovery and development
- experience of the application of these tools to specific drug classes of clinical
- knowledge of the range of research tools available for this process.
||BC2014 AND PC2002 AND PC2004 AND PC2006 AND HS2401 AND PC2001 AND PC2003 AND PC2201
Study Period 2
|Census Date 28-Aug-2014
||Dr Chris Glasson
||Dr Chris Glasson, Assoc. Professor Michael Oelgemoeller, Dr George Vamvounis, Assoc. Professor Bruce Bowden, Dr Ioana Bowden.
- 30 hours lectures
- 6 hours tutorials
- 6 hours workshops/Seminars
||end of semester exam (70%); assignments (30%).
Minor variations might occur due to the continuous Subject quality improvement process,
and in case
of minor variation(s) in assessment details, the Subject Outline represents the latest